Overview
Watchlist
Equities
Crypto
Soon
Popular
Cookies
Terms of Service
Privacy Policy
Home
© 2025 FYStats 
Home
Equities
KNSA
Fundamentals

Kiniksa Pharmaceuticals International, Plc

KNSA

Chart
Fundamentals
Soon
Sentiment
Soon
Options

Revenue

122.54M
▲10.32M▲9.20%
3 Months Change

Assets

580.55M
▲25.26M▲4.55%
3 Months Change

Liabilities

142.12M
▲23.83M▲20.14%
3 Months Change

Free Cash Flow

3.90M
▲8.19M▲190.96%
12 Months Change

Revenue/Cost Of Revenue

Loading...

Net Profit/Loss

Loading...

Assets/Liabilities

Loading...

Cash Flows

Loading...

Earnings Per Share

Loading...

Outstanding Shares

Loading...

Recent Quarterly and Annual Filings

2024-10-29
Form 10-Q
ID: 0001558370-24-013840
2024-10-29
Form 8-K
ID: 0001104659-24-112034
2024-10-07
Form 8-K
ID: 0001104659-24-106690
2024-07-25
Form 10-Q
ID: 0001558370-24-010181
2024-07-23
Form 8-K
ID: 0001104659-24-081717
2024-06-25
Form 8-K
ID: 0001104659-24-074763
2024-06-14
Form 8-K
ID: 0001104659-24-071787
2024-06-05
Form 8-K
ID: 0001104659-24-068694
2024-04-25
Form 10-Q
ID: 0001558370-24-005774
2024-04-23
Form 8-K
ID: 0001104659-24-050335